These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 21356265)
41. Structural and energetic analysis to provide insight residues of CYP2C9, 2C11 and 2E1 involved in valproic acid dehydrogenation selectivity. Bello M; Mendieta-Wejebe JE; Correa-Basurto J Biochem Pharmacol; 2014 Jul; 90(2):145-58. PubMed ID: 24794636 [TBL] [Abstract][Full Text] [Related]
42. Intramolecular heme ligation of the cytochrome P450 2C9 R108H mutant demonstrates pronounced conformational flexibility of the B-C loop region: implications for substrate binding. Roberts AG; Cheesman MJ; Primak A; Bowman MK; Atkins WM; Rettie AE Biochemistry; 2010 Oct; 49(40):8700-8. PubMed ID: 20815369 [TBL] [Abstract][Full Text] [Related]
43. Investigation of ligand selectivity in CYP3A7 by molecular dynamics simulations. Fan JR; Zheng QC; Cui YL; Li WK; Zhang HX J Biomol Struct Dyn; 2015; 33(11):2360-7. PubMed ID: 26065334 [TBL] [Abstract][Full Text] [Related]
44. Insights into regioselective metabolism of mefenamic acid by cytochrome P450 BM3 mutants through crystallography, docking, molecular dynamics, and free energy calculations. Capoferri L; Leth R; ter Haar E; Mohanty AK; Grootenhuis PD; Vottero E; Commandeur JN; Vermeulen NP; Jørgensen FS; Olsen L; Geerke DP Proteins; 2016 Mar; 84(3):383-96. PubMed ID: 26757175 [TBL] [Abstract][Full Text] [Related]
45. Interaction between Human Serum Albumin and antidiabetic compounds and its influence on the O2((1)Δg)-mediated degradation of the protein. Challier C; Beassoni P; Boetsch C; García NA; Biasutti MA; Criado S J Photochem Photobiol B; 2015 Jan; 142():20-8. PubMed ID: 25490375 [TBL] [Abstract][Full Text] [Related]
46. Fluoride as a probe for H-bonding interactions in the active site of heme proteins: the case of Thermobifida fusca hemoglobin. Nicoletti FP; Droghetti E; Boechi L; Bonamore A; Sciamanna N; Estrin DA; Feis A; Boffi A; Smulevich G J Am Chem Soc; 2011 Dec; 133(51):20970-80. PubMed ID: 22091531 [TBL] [Abstract][Full Text] [Related]
47. Molecular dynamics simulation of PNPLA3 I148M polymorphism reveals reduced substrate access to the catalytic cavity. Xin YN; Zhao Y; Lin ZH; Jiang X; Xuan SY; Huang J Proteins; 2013 Mar; 81(3):406-14. PubMed ID: 23042597 [TBL] [Abstract][Full Text] [Related]
48. Stabilization and spectroscopic characterization of the dioxygen complex of wild-type cytochrome P4502B4 (CYP2B4) and its distal side E301Q, T302A and proximal side F429H mutants at subzero temperatures. Perera R; Sono M; Kinloch R; Zhang H; Tarasev M; Im SC; Waskell L; Dawson JH Biochim Biophys Acta; 2011 Jan; 1814(1):69-75. PubMed ID: 20637316 [TBL] [Abstract][Full Text] [Related]
50. Structural basis for cooperative binding of azoles to CYP2E1 as interpreted through guided molecular dynamics simulations. Levy JW; Hartman JH; Perry MD; Miller GP J Mol Graph Model; 2015 Mar; 56():43-52. PubMed ID: 25544389 [TBL] [Abstract][Full Text] [Related]
52. F429 Regulation of Tunnels in Cytochrome P450 2B4: A Top Down Study of Multiple Molecular Dynamics Simulations. Mancini G; Zazza C PLoS One; 2015; 10(9):e0137075. PubMed ID: 26415031 [TBL] [Abstract][Full Text] [Related]
53. Re-engineering of CYP2C9 to probe acid-base substrate selectivity. Tai G; Dickmann LJ; Matovic N; DeVoss JJ; Gillam EM; Rettie AE Drug Metab Dispos; 2008 Oct; 36(10):1992-7. PubMed ID: 18606741 [TBL] [Abstract][Full Text] [Related]
54. Insights into molecular mechanisms of drug metabolism dysfunction of human CYP2C9*30. Louet M; Labbé CM; Fagnen C; Aono CM; Homem-de-Mello P; Villoutreix BO; Miteva MA PLoS One; 2018; 13(5):e0197249. PubMed ID: 29746595 [TBL] [Abstract][Full Text] [Related]